These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26429564)

  • 1. Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
    Roger C; Nucci B; Louart B; Friggeri A; Knani H; Evrard A; Lavigne JP; Allaouchiche B; Lefrant JY; Roberts JA; Muller L
    J Antimicrob Chemother; 2016 Jan; 71(1):208-12. PubMed ID: 26429564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
    Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
    Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize
    Boidin C; Bourguignon L; Cohen S; Roger C; Lefrant JY; Roberts JA; Allaouchiche B; Lepape A; Friggeri A; Goutelle S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
    Moffett BS; Rossano JW
    Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PK/PD targets of amikacin and gentamicin in ICU patients.
    Coste A; Deslandes G; Jalin L; Corvec S; Caillon J; Boutoille D; Grégoire M; Bretonnière C
    Med Mal Infect; 2020 Nov; 50(8):709-714. PubMed ID: 31883736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units.
    Allou N; Allyn J; Levy Y; Bouteau A; Caujolle M; Delmas B; Valance D; Brulliard C; Martinet O; Vandroux D; Montravers P; Augustin P
    Anaesth Crit Care Pain Med; 2016 Oct; 35(5):331-335. PubMed ID: 27133236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Lugo G; Castañeda-Hernández G
    Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Aliska G; Setiabudy R; Purwantyastuti P; Karuniawati A; Sedono R; Dewi TU; Azwar MK
    Acta Med Indones; 2017 Jul; 49(3):227-235. PubMed ID: 29093233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department.
    Cobussen M; Stassen PM; Posthouwer D; van Tiel FH; Savelkoul PHM; Havenith T; Haeseker MB
    PLoS One; 2019; 14(1):e0210012. PubMed ID: 30668571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
    Marsot A; Hraiech S; Cassir N; Daviet F; Parzy G; Blin O; Papazian L; Guilhaumou R
    Int J Antimicrob Agents; 2020 Oct; 56(4):106124. PubMed ID: 32739478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.
    Panidis D; Markantonis SL; Boutzouka E; Karatzas S; Baltopoulos G
    Chest; 2005 Aug; 128(2):545-52. PubMed ID: 16100136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
    De Winter S; van Hest R; Dreesen E; Annaert P; Wauters J; Meersseman W; Van den Eede N; Desmet S; Verelst S; Vanbrabant P; Peetermans W; Spriet I
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):653-663. PubMed ID: 34297338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.